Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas”

1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,756
Index total 30,257
Page 59 / 74

Quick answer

This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,756 results for “The Board of Regents of the University of Texas” · 30,257 patents in full index Clear search

  1. US 7429616

    Synthesis and complete stereochemical assignment of psymberin/irciniastatin for use as antitumor compounds

    The Board of Regents of the University of Texas System · Granted Sep 30, 2008 · Expires Sep 25, 2028

    granted
  2. US 7423015

    Antihelminthic drugs as a treatment for hyperproliferative diseases

    The Board of Regents of the University of Texas System · Granted Sep 9, 2008 · Expires Sep 4, 2028

    granted
  3. US 7422738

    Combined cancer treatment methods using antibodies to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Sep 9, 2008 · Expires Sep 4, 2028

    granted
  4. US 7420030

    Aminopeptidase A (APA) targeting peptides for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Sep 2, 2008 · Expires Aug 28, 2028

    granted
  5. US 7420100

    Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression

    The Board of Regents of the University of Texas System · Granted Sep 2, 2008 · Expires Aug 28, 2028

    granted
  6. US 7413781

    Gels for encapsulation of biological materials

    The Board of Regents of the University of Texas System · Granted Aug 19, 2008 · Expires Aug 14, 2028

    granted
  7. US 7410950

    Peptides of CaV2.2 that inhibit pain

    The Board of Regents of the University of Texas System · Granted Aug 12, 2008 · Expires Aug 7, 2028

    granted
  8. US 7410758

    Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, including CIN

    The Board of Regents of the University of Texas System · Granted Aug 12, 2008 · Expires Aug 7, 2028

    granted
  9. US 7405314

    Compounds and methods for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Jul 29, 2008 · Expires Jul 24, 2028

    granted
  10. US 7405287

    Method of treating a cancer

    The Board of Regents of the University of Texas System · Granted Jul 29, 2008 · Expires Jul 24, 2028

    granted
  11. US 7405286

    Stars—A muscle-specific actin-binding protein

    The Board of Regents of the University of Texas System · Granted Jul 29, 2008 · Expires Jul 24, 2028

    granted
  12. US 7384909

    Anti-viral treatment methods using phosphatidylethanolamine-binding peptides linked to anti-viral agents

    The Board of Regents of the University of Texas System · Granted Jun 10, 2008 · Expires Jun 5, 2028

    granted
  13. US 7378386

    Anti-viral treatment methods using phosphatidylethanolamine-binding peptide derivatives

    The Board of Regents of the University of Texas System · Granted May 27, 2008 · Expires May 22, 2028

    granted
  14. US 7371364

    Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy

    The Board of Regents of the University of Texas System · Granted May 13, 2008 · Expires May 8, 2028

    granted
  15. US 7368232

    High-throughput assay for virus entry and drug screening

    The Board of Regents of the University of Texas System · Granted May 6, 2008 · Expires May 1, 2028

    granted
  16. US 7365096

    Methods for selectively inhibiting Janus tyrosine kinase 3 (Jak3)

    The Board of Regents of the University of Texas System · Granted Apr 29, 2008 · Expires Apr 24, 2028

    granted
  17. US 7354912

    Unique compositions of zwitterionic phospholipids and bisphosphonates and use of the compositions as bisphosphate delivery systems with reduced GI toxicity

    The Board of Regents of the University of Texas System · Granted Apr 8, 2008 · Expires Apr 3, 2028

    granted
  18. US 7348153

    Method for identifying and designing immunogenic peptides

    The Board of Regents of the University of Texas System · Granted Mar 25, 2008 · Expires Mar 20, 2028

    granted
  19. US 7344829

    Methods for detecting the efficacy of anticancer treatments

    The Board of Regents of the University of Texas System · Granted Mar 18, 2008 · Expires Mar 13, 2028

    granted
  20. US 7344724

    UspA1 and UspA2 antigens of Moraxella catarrhalis

    The Board of Regents of the University of Texas System · Granted Mar 18, 2008 · Expires Mar 13, 2028

    granted
  21. US 7338758

    Compositions and methods for the identification, assessment, prevention and therapy of human cancers

    The Board of Regents of the University of Texas System · Granted Mar 4, 2008 · Expires Feb 28, 2028

    granted
  22. US 7332321

    Viral fibers

    The Board of Regents of the University of Texas System · Granted Feb 19, 2008 · Expires Feb 14, 2028

    granted
  23. US 7332469

    Intrapleural single-chain urokinase alone or complexed to its soluble receptor protects against pleural adhesions

    The Board of Regents of the University of Texas System · Granted Feb 19, 2008 · Expires Feb 14, 2028

    granted
  24. US 7329642

    β-2-glycoprotein is an inhibitor of angiogenesis

    The Board of Regents of the University of Texas System · Granted Feb 12, 2008 · Expires Feb 7, 2028

    granted